Cognetivity Neurosciences Ltd. focuses on developing cognitive assessment tools leveraging artificial intelligence, primarily targeting the early detection of neurodegenerative diseases. Its flagship product, the Cognition Assessment Tool, is designed to be used in clinical settings across North America and Europe, providing a competitive edge through its innovative technology and ease of integration into existing healthcare systems.
HealthcareMedical - Healthcare Information Serviceslow - The company has high fixed costs associated with technology development and regulatory compliance, with limited revenue generation currently.